Do CRHR1 rs110402 and NPSR1 rs324981 variants increase stress-related anxiety or PTSD symptoms?

Genetic variations in the CRHR1 and NPSR1 genes significantly shape individual vulnerability to stress by altering core neuroendocrine and central arousal pathways.

Neurobiological and Mechanistic Pathways

• HPA-Axis Regulation (CRHR1): The CRHR1 rs110402 polymorphism modulates corticotropin-releasing hormone receptor 1 function, altering systemic cortisol reactivity and functional connectivity within cortico-limbic networks—specifically the amygdala and dorsal anterior cingulate cortex.
• Arousal and Threat Processing (NPSR1): The NPSR1 rs324981 T (Ile107) gain-of-function allele increases neuropeptide S receptor expression. This amplifies basolateral amygdala reactivity to objective threats and heightens bed nucleus of the stria terminalis (BNST) activation during anticipated threats, resulting in sustained hyper-arousal and shortened sleep duration.

Clinical Vulnerability and Environmental Interactions

• Impaired Fear Extinction: The combination of dysregulated cortisol dynamics and hyper-reactive limbic circuitry impairs top-down prefrontal control, disrupting the cognitive and physiological processes required for fear extinction.
• Susceptibility to Anxiety and PTSD: These genetic phenotypes directly increase anxiety sensitivity, panic-related symptoms, and PTSD severity.
• Gene-Environment Moderation: The phenotypic expression of both variants is highly contingent upon environmental context, demonstrating a pronounced interaction with childhood trauma and early-life adversity to dictate overall clinical severity.

Bottom line

• The CRHR1 rs110402 and NPSR1 rs324981 variants collectively alter endocrine and neural stress-response networks. This neurobiological dysregulation impairs fear extinction and increases susceptibility to anxiety and PTSD, particularly when combined with a history of early-life adversity.